银诺医药-B荣获“格隆汇金格奖·年度卓越创新力IPO”奖

Core Viewpoint - The "Annual Excellence Innovation IPO" award was presented to Silver诺医药-B (02591.HK) during the "Technology Empowerment · Capital Breakthrough" online sharing session held by 格隆汇 on December 22, recognizing the company's achievements in product, model, and organizational innovation over the past year [1] Group 1 - The award aims to honor newly listed companies that have achieved excellent results through continuous innovation in response to market trends [1]